QNRX (Quoin Pharmaceuticals) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QNRX Quoin Pharmaceuticals Ltd QNRX
26 GF Score
Price $4.15
! 1 Warning Sign
View Full Analysis

What is Quoin Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

QNRX
26GF Score
Quoin Pharmaceuticals Ltd QNRX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quoin Pharmaceuticals Business Description

Address 42127 Pleasant Forest Court, Ashburn, VA, USA, 20148-7349
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
26GF Score

Get the complete analysis for QNRX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price